Florida / New York
Ph: 561.316.3330
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
HeartBeam has developed the HeartBeam AIMIGo System, a personal, portable and easy-to-use VECG solution to assist patients and their clinicians in assessing cardiac symptoms.
Christian Zwicky, Chief Executive Officer at Deep Breath Intelligence, emphasized that this is a major milestone for DBI, as a startup that has invested so much in researching and developing this revolutionary method: “This initiative is a critical step in our mission to broaden the range of medical application for early disease testing in the years to come. We really enjoyed the close and professional collaboration with Effectum Medical and the HTEC team which allowed us to identify early critical topics for CE mark, accomplish this project on time and within the targeted budget.”
Centinel Spine notes these live surgeries are intended for spine and anterior access surgeons and will be viewable by virtual attendees with supported Q&A
Exactech notes the Vantage Ankle was first launched in the U.S. in 2016 and received clearance in Chile earlier this year. It is designed to recreate the natural biomechanics of the ankle joint through its curved talus component, which aligns with the talus’ trabecular bone structure, and tibial implant.
Medtronic Extravascular ICD system is a first-of-its-kind implantable defibrillator, designed to avoid certain risks of traditional, transvenous ICDs because its lead (thin wire) is placed outside the heart and veins, under the sternum (breastbone). The system offers anti-tachycardia pacing (ATP), pause prevention pacing, and a device similar in size, shape, and battery longevity to transvenous ICDs. Using a minimally invasive approach, the device is implanted below the left armpit (in the left mid-axillary region).
The coraCatheters family of novel devices is the latest in the Reflow portfolio, which includes the Wingman™ and Spex™ Catheters. As the company makes its mark in the coronary space, they are expanding their sales team to support both current and future innovations.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330